Expert shares top five atopic dermatitis–related questions he fields

Counseling about systemic therapy includes shared decision-making, Dr. Lawrence F. Eichenfield says.

Two questions can help establish a diagnosis of hidradenitis suppurativa

There is no perfect outcome measure yet, but progress is being made.

Certain opioids hold promise for treating itch

Difelikefalin is the first FDA-approved treatment for uremic pruritus associated with dialysis.

Validity of commercial serologic tests for dermatomyositis still questionable

“The testing in research laboratories is not widely available and the results are often delayed by weeks to months.”

Rosacea is in the eye of the beholder, expert says

As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.

Topical options for acne patients continue to expand

In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and older.

Infantile hemangiomas: Accurate diagnosis is crucial

Consider propranolol a “life changer” in extreme cases.

Managing hyperhidrosis, HS: Ask questions first

Ask the patient a simple question: “What bothers you the most?”

Recent psoriasis pathophysiology insights carry treatment implications

“The primary problem in psoriasis is not so much the inflammatory activity, but the ability to turn off the activity.”

Neoadjuvant immunotherapy shows promise in stage III melanoma

There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.

Pages